Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
02/16/1994 | EP0582693A1 Myotonin receptors and screening methods |
02/16/1994 | EP0500589B1 Purified protein and bioactive pharmaceutical |
02/16/1994 | EP0449897B1 A pure factor i protein and a process for producing said protein |
02/16/1994 | EP0387285B1 Emulsifiers |
02/16/1994 | CN1082112A Derivatives of adipogenesis inhibitory factor, their preparation and their use |
02/16/1994 | CN1082110A Isolation and cloning of a protein with tyrosine-phosphatase activity |
02/16/1994 | CN1082053A Synthetic polypeptides |
02/16/1994 | CN1081909A Methods and compositions for the treatment of diseases with interferon while reducing side effects |
02/15/1994 | US5286852 Antibodies specific towards HIV-1 gp 48 |
02/15/1994 | US5286849 Purification of factor IX |
02/15/1994 | US5286847 Replacing the arginine residue with glycine at position 11 of the mature form; reduced bioactivity without loss of receptor binding affinity |
02/15/1994 | US5286716 Inhibitor of the proliferation of endothelial cells |
02/15/1994 | US5286714 Synthetic isohirudins with improved stability |
02/15/1994 | US5286654 Contacting sample with isolated activin receptor polypeptide, determining if binding has occurred |
02/15/1994 | US5286653 Method for detecting the γ,δ T cell receptor |
02/15/1994 | US5286648 Culture of Streptosporangium carneum or mutants |
02/15/1994 | US5286645 Source of heparin binding and non-heparin binding growth factors |
02/15/1994 | US5286644 Rat osteosarcoma cell line OSR-2 |
02/15/1994 | US5286643 Rat osteosarcoma cell line OSR-8 |
02/15/1994 | US5286642 Rat osteosarcoma cell line OSR5TR2 |
02/15/1994 | US5286639 With DNA coding for newcastle disease virus-derived hemagglutinin renuramindase a non-essential genome region |
02/15/1994 | US5286487 Covalent angiogenin/RNase hybrids |
02/15/1994 | US5286486 Isolated DNA sequence encoding insecticidal toxin |
02/15/1994 | US5286485 Process for controlling lepidopteran pests |
02/15/1994 | US5286484 Bactericides |
02/15/1994 | US5286483 50 kilodalton antigen obtained from the intraerythrocytic phase of plasmodium falciparum |
02/15/1994 | US5286482 Methods and compositions for inducing monocyte cytotoxicity |
02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
02/15/1994 | CA1327095C Synthetic peptides derived from the alpha-subunit of human glycoprotein hormones |
02/15/1994 | CA1326996C Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
02/14/1994 | CA2103635A1 Aqueous dispersions of zein and preparations thereof |
02/13/1994 | CA2103933A1 Mycobacterium dna fragments, amplification primers, hybridization probes, reactants and a process for the detection of mycobacteria |
02/10/1994 | DE4301904A1 Hypoglycosylierte recombinante Glucoseoxidase Hypoglycosylated Recombinant glucose oxidase |
02/10/1994 | DE4226340A1 DNA encoding aphrodisin with an N-terminal signal peptide |
02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
02/09/1994 | EP0582541A2 Process for creating conjugation-proficient Bacillus thuringiensis strains |
02/09/1994 | EP0582450A2 Anti-oxytocin receptor antibodies and methods for their production |
02/09/1994 | EP0582244A2 Yeast strains with impaired N-glycosylation |
02/09/1994 | EP0582243A2 HCV peptide antigens and a method of testing for the hepatitis C virus (HCV) |
02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
02/09/1994 | EP0581836A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
02/09/1994 | EP0366770B1 Liposomes coupled to hormones |
02/09/1994 | EP0343227B1 Selective removal of immune complexes |
02/09/1994 | CN1081716A Recombiant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
02/09/1994 | CN1081715A Stem cell proliferation factor |
02/08/1994 | US5284999 DNA encoding a pituitary-specific thyroid hormone receptor |
02/08/1994 | US5284937 Antivirals, antitumor agents and immunomodulators |
02/08/1994 | US5284936 Water insoluble crosslinked polylactams having glutamic acid, lysine and aspartic acid monomers, for disposasble products |
02/08/1994 | US5284935 Major histocompatibility complex |
02/08/1994 | US5284934 Separating a hemmagglutinin-coupled polyoxyethylene or -propylene glycol from a carbohydrate by chromatography; purification; nontoxic immunomodulators |
02/08/1994 | US5284933 Fusion protein linked to affinity protein having two or more neighboring histidines |
02/08/1994 | US5284932 Reducing with dithiothreitol, carboxymethylation, digestion, sequencing |
02/08/1994 | US5284931 Intercellular adhesion molecules, and their binding ligands |
02/08/1994 | US5284849 Renin inhibitors |
02/08/1994 | US5284832 For treating anemia |
02/08/1994 | US5284830 Stimulating cartilage repair |
02/08/1994 | US5284827 Systemic treatment of metastatic cancer with platelet factor 4 |
02/08/1994 | US5284768 Signal peptide, DNA sequences coding for the latter, expression vectors carrying one of these sequences, gram-negative bacteria transformed by these vectors, and process for the periplasmic production of a polypeptide |
02/08/1994 | US5284764 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
02/08/1994 | US5284763 Nucleic acid encoding TGF-β and its uses |
02/08/1994 | US5284760 Inserting new DNA or RNA sequences into DNA using polymerase chain reaction with oligonucleotide primers |
02/08/1994 | US5284756 Treatment of bone disorders |
02/08/1994 | US5284755 DNA encoding leukemia inhibitory factor receptors |
02/08/1994 | US5284751 Detecting thrombi, clotting disorders |
02/08/1994 | US5284750 Treating human serum with monoclonal antibodies to antigenic determinants of a1-antitrypsin |
02/08/1994 | US5284746 Methods of producing hybrid G protein-coupled receptors |
02/08/1994 | US5284664 Administering mammalian liver extract |
02/08/1994 | CA2103533A1 Hcv peptide antigens and method of determining hcv |
02/08/1994 | CA2101610A1 Production of bacillus entomotoxins in methylotrophic yeast |
02/08/1994 | CA1326940C Purification of lfa-3 |
02/08/1994 | CA1326835C Eel growth hormone |
02/06/1994 | CA2101878A1 Platelet increasing-agent |
02/06/1994 | CA2101586A1 Ampa-binding human glur4 receptors |
02/03/1994 | WO1994002856A1 Peptides useful as internal standards for microsequencing and methods for their use |
02/03/1994 | WO1994002851A1 Clinical test for detection of alzheimer's disease |
02/03/1994 | WO1994002633A1 Diagnostic method |
02/03/1994 | WO1994002626A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
02/03/1994 | WO1994002625A1 Process for isolating recombinant polypeptides |
02/03/1994 | WO1994002619A1 A brassica regulatory sequence for root-specific or root-abundant gene expression |
02/03/1994 | WO1994002617A2 Cloning and expression of a lipase modulator gene from pseudomonas pseudoalcaligenes |
02/03/1994 | WO1994002614A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
02/03/1994 | WO1994002613A1 Anti-feline immunodeficiency virus (fiv) vaccines |
02/03/1994 | WO1994002612A1 Anti-feline immunodeficiency virus (fiv) vaccines |
02/03/1994 | WO1994002611A2 Recombinant human erythropoietin with altered biological activity |
02/03/1994 | WO1994002606A1 Inhibition of retroviral expression by interferon-induced cellular genes and proteins |
02/03/1994 | WO1994002605A1 Dna encoding the human a1 adenosine receptor |
02/03/1994 | WO1994002604A1 RECOMBINANT CDw52 ANTIGEN |
02/03/1994 | WO1994002598A1 Purified chitinases and use thereof |
02/03/1994 | WO1994002595A1 Method and reagent for treatment of animal diseases |
02/03/1994 | WO1994002591A1 Genetic alteration of insect symbionts |
02/03/1994 | WO1994002590A1 β3-ADRENERGIC RECEPTOR PROTEIN AND DNA ENCODING SAME |
02/03/1994 | WO1994002589A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
02/03/1994 | WO1994002514A2 Derivatives of bauhinia purpurea lectin and their use as larvicides |
02/03/1994 | WO1994002513A2 Derivatives of eranthis hyemalis lectin |
02/03/1994 | WO1994002512A1 Carboxy terminal il-6 muteins |
02/03/1994 | WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta |
02/03/1994 | WO1994002510A2 Analogs of pth |
02/03/1994 | WO1994002509A1 Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases. |
02/03/1994 | WO1994002508A2 Polypeptide antigens of mycobacterium bovis |
02/03/1994 | WO1994002507A2 Methods for detecting pre-clinical iddm |